Tech giant Nvidia surges past Saudi Aramco, claiming the title of world's third-most valuable company, with a historic $2.06 trillion market cap driven by advances in AI and computing technology.

Amprion's innovative αSyn seed amplification assay, the SYNTap® Biomarker Test, takes center stage at the AD/PD™ 2024 conference, showcasing its pivotal role in the accurate detection and potential treatment of neurodegenerative diseases such as Alzheimer's and Parkinson's.

New research predicts a staggering expansion in the manga market, driven by digital advancements and cross-cultural storytelling, with a projected 15.89% CAGR from 2023 to 2028.

In an unexpected dialogue, Google's Sergey Brin shares insights on AI development mistakes, the potential shift in business models, and the future of AI-driven technology.

ICEYE, a leader in Earth Observation, successfully launches three new satellites equipped with groundbreaking radar technology, boosting global monitoring and intelligence with 25 cm resolution imaging capabilities. Discover the impact of this significant technological advancement for a variety of critical applications.

China's marked 28.6% increase in technology transactions propels the country into a new paradigm of innovation-led economic development, showcasing a strategic vision to revolutionize its industrial landscape with high-tech, efficiency, and quality.

GenScript Biotech Corporation and Roche bolster their collaborative efforts to set new industry standards in medical diagnostics and life science research, promising revolutionary advancements.

Meta Platforms, Inc. encounters a significant service disruption affecting global users of Facebook, Instagram, Threads, and Messenger, leading to widespread login issues and connectivity concerns.

As digital data becomes ever more critical, Workstream.io's latest innovation emerges as a game-changer in incident alerting and workflow automation, offering seamless dbt integration catered to the needs of data teams.

GenScript Biotech Corporation welcomes Dr. Carl June, a revolutionary figure in immunotherapy, to its Scientific Advisory Board, promising to enhance innovative life science research and accelerate therapeutic developments.